However, the HER2 positivity definition is based on clinical response to anti‐HER2 therapy and was extended to include breast cancer (BC) with equivocal protein expression (HER2 IHC score 2+) with evidence of HER2 gene amplification using ISH techniques [1, 2]. Here, ERBB2 is linked to breast carcinoma.